Munich, Germany, January 17, 2011 / B3C newswire / - AMSilk announces the appointment of Jeff Davis, a senior business executive, to AMSilk’s advisory board.
Jeff Davis brings with him more than 23 years of executive experience in sales, marketing and general management in global pharmaceuticals, consumer package goods and beauty businesses from Procter & Gamble, a world leader in consumer care products. Jeff served in several key roles at P&G including: director of global new business development at P&G Pharmaceuticals; he spearheaded the opening of new markets in Eastern Europe in the early nineties and served as global Vice President & General Manager of Wella, Germany, after its acquisition through P&G. Jeff has worked in 6 different product groups and 5 different countries.
More recently, as the CEO of Orabrush Inc., an innovative oral care product company targeting the young consumer, Jeff has developed groundbreaking marketing strategies for consumer products using social media with unprecedented success. He, lectures as an adjunct Professor at the David Eccles School of Business at the University of Utah, and advises Ernst & Young’s business consulting practice for their elite worldwide clients.
Jeff will advise AMSilk on general business and product strategies. „Jeff’s contributions to our product strategy are already significant and this couldn’t have come at a better time,“ says Axel Leimer, CEO of AMSilk. „AMSilk’s ambitious goals of bringing Spidersilk and related novel high performance materials to market will benefit greatly from his experience.“
„I am excited to work with AMSilk. Having followed AMSilk for some time, I have seen the focus shift from technology to product development,“ says Jeff. „Spidersilk is a true cleantech material for safer products with a new range of properties. It shows what is possible if we learn from nature.”
Spider silk has attracted human interest for thousands of years, mainly due to its toughness and ductility. The material is also biocompatible and can be used in formulations for specialized coatings, films, nonwovens and in pharmaceuticals. As with most biomaterials, spider silk has evolved over millions of years resulting in a combination of properties that far exceeds any man-made material. Until recently, it was not possible to utilize this high-performance material for technical applications, because no process was known to produce enough spider silk. AMSilk is the first company to produce Spidersilk biopolymers, inspired by the proteins of web-weaving spiders on an industrial scale. This makes possible a completely new set of technical products as well as major improvements for already existing products. AMSilk, a spin-off from the Technische Universität München, was founded in 2008 and is located in the IZB in Martinsried near Munich. AMSilk’s investors are MIG Funds and AT Newtec, Munich. For more information visit the website at www.amsilk.com.
AMSilk and Spidersilk are registered trademarks in the European Union and trademark appli¬cations in the USA of AMSilk GmbH, Germany.
Axel H. Leimer
Am Klopferspitz 19 im IZB
82152 Planegg/Martinsried, Germany
Tel: +49 (0)89 38156-4430